CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Net Sales	$ 15,856,539	$ 15,559,439
Cost of Sales	14,743,613	14,549,047
Gross Profit	1,112,926	1,010,392
Selling and Marketing	2,072,798	3,102,378
General and Administrative	5,273,433	6,220,499
Research and Product Development	1,821,488	497,276
Operating Loss	(8,054,793)	(8,809,761)
Other Income (Expense)
Realized Gain on Investments	1,929	13,888
Interest Expense	(101,951)	0
Interest Income	171,077	117,526
Total Other Income	71,055	131,414
Net Loss	$ (7,983,738)	$ (8,678,347)
Basic and Diluted Net Loss per Share (in dollars per share)	$ (0.12)	$ (0.15)
Basic and Diluted Weighted Average Shares Outstanding (in shares)	67,518,240	57,098,947